
Doctoral Researcher in Oncology with expertise in translational cancer research and triple-negative breast cancer. Experienced in interpreting complex scientific data, communicating evidence to diverse audiences, and supporting evidence-based decision-making. Skilled in stakeholder engagement, medical education, and translating preclinical findings into clinically relevant insights to inform therapeutic strategies and improve patient outcomes.
Royal Society of Chemistry (RSC), Member, 2022–Present